From: Physical activity and metabolic health in chronic kidney disease: a cross-sectional study
 | Physical activity | ||
---|---|---|---|
 | Tertile 1 (≤375 CPM) | Tertile 2 (375 < CPM ≤ 631) | Tertile 3 (> 631 CPM) |
N | 25 | 25 | 26 |
Demographics: | |||
 Age (years) | 69.5 (10.5) | 63.0 (12.5) | 58.1 (11.2) |
 Female sex | 9 (36) | 11 (44) | 14 (54) |
 Race | |||
  White | 20 (80) | 21 (84) | 20 (77) |
  Black | 4 (16) | 2 (8) | 5 (19) |
  Other | 1 (4) | 2 (8) | 1 (4) |
Medical history & lifestyle: | |||
 Cardiovascular disease | 13 (52) | 2 (8) | 3 (12) |
 Current smoking | 5 (20) | 1 (4) | 5 (19) |
 Physical activity (adjusted activity score), median | 67.0 (57.0–73.0) | 76.0 (71.0–82.0) | 78.5 (74.5–82.8) |
 Average Sedentary vs Active Time (%) | 74.5 | 63.0 | 49.8 |
Medication use: | |||
 Any antihypertensive medication | 20 (80) | 16 (64) | 16 (62) |
 Number of antihypertensive medications | 2.3 (1.5) | 1.5 (1.8) | 1.3 (1.5) |
 Any lipid-lowering medication | 9 (36) | 8 (32) | 5 (19) |
  Statin | 9 (36) | 8 (32) | 4 (15) |
  Fibrate | 3 (12) | 1 (4) | 1 (4) |
  Niacin | 2 (8) | 0 (0) | 1 (4) |
Physical characteristics: | |||
 Height (cm) | 172.5 (9.3) | 170.5 (10.0) | 173.5 (11.8) |
 Weight (kg) | 94.9 (20.1) | 85.8 (15.4) | 80.1 (20.8) |
 Fat mass (kg) | 35.7 (13.3) | 31.2 (12.4) | 26.3 (11.3) |
 BMI (kg/m2) | 31.8 (6.2) | 29.6 (5.3) | 26.4 (5.3) |
 Systolic blood pressure (mm Hg) | 135.1 (14.4) | 130.7 (12.1) | 124.3 (17.2) |
 Diastolic blood pressure (mm Hg) | 78.0 (9.6) | 79.9 (8.4) | 77.4 (11.3) |
Laboratory data: | |||
 Serum creatinine (mg/dL), median | 1.6 (1.2–1.9) | 1.4 (1.0–1.8) | 1.0 (0.8–1.5) |
 Serum cystatin C (mg/L), median | 1.6 (1.1–2.0) | 1.2 (1.0–1.6) | 1.0 (0.8–1.4) |
 Estimated GFR (mL/min/1.73 m2) | 44.7 (21.7) | 54.8 (28.4) | 71.6 (26.5) |
 eGFR < 60 mL/min.1.73 m2 | 21 (84) | 15 (60) | 11 (42) |
 Urine AER, (mg/24 h) median | 24.6 (8.2–137.4) | 9.7 (5.3–91.7) | 8.9 (5.6–95.4) |